You are here

Clinical Trials: Cord Blood

Condition:   Ischemic Bowel Disease
Intervention:   Other: Human Umbilical Cord blood mononuclear cells
Sponsor:   Qianfoshan Hospital
Condition:   Pediatric Cancer
Intervention:   Biological: Granulocytes
Sponsors:   University of Manchester;   Children's Cancer and Leukaemia Group
Condition:   Sexual Dysfunction Male
Intervention:   Biological: Umbilical Cord-Derived Mesenchymal Stem Cell for Male Patients with Sexual Deficiency
Sponsor:   Vinmec Research Institute of Stem Cell and Gene Technology
Not yet recruiting
Condition:   Acute Leukemia
Interventions:   Procedure: Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation;   Procedure: haploidentical hematopoietic stem cell transplantation
Sponsor:   Institute of Hematology & Blood Diseases Hospital
Not yet recruiting
Condition:   Neuroblastoma
Interventions:   Drug: Anti Thymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide injection;   Drug: Topotecan;   Drug: Melphalan;   Drug: Thiotepa;   Drug: Busulfan;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Drug: Methotrexate
Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
Condition:   Ischemic Stroke
Interventions:   Biological: UC-MSC infusion via intravenous route;   Biological: UC-MSC infusion via intrathecal route;   Other: standard stroke treatment and rehabilitation therapy
Sponsor:   Vinmec Research Institute of Stem Cell and Gene Technology
Conditions:   Hematological Malignancies;   Hematopoietic Stem Cell Transplantation
Interventions:   Other: PBSCs;   Other: Cord;   Other: BMSCs
Sponsors:   Nanfang Hospital of Southern Medical University;   Anhui Provincial People's Hospital Affiliated to University of Science and Technology of China;   The Seventh Affiliated Hospital of Sun Yat-sen University;   The First People's Hospital of Guangzhou;   The First People's Hospital of Chenzhou
Condition:   Knee Osteoarthritis
Interventions:   Biological: SMUP-IA-01(low dose);   Biological: SMUP-IA-01(mid dose);   Drug: Active Control Group Sodium chloride
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Conditions:   Neonatal Necrotizing Enterocolitis;   Growth and Development;   Preterm Infants;   Nutrition
Interventions:   Other: Autologous Umbilical Cord Blood Mononuclear Cells Therapy;   Drug: 0.9% Sodium Chloride
Sponsor:   Guangdong Women and Children Hospital
Conditions:   Refractory Idiopathic Aplastic Anemia;   Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
Intervention:   Other: Allogenic transplantation
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting